BusinessAmarantus Appoints Michael T. Ropacki, PhD as Chief Medical Advisor for Alzheimer's Blood Diagnostic LymPro Test ProgramBy Nasdaq OMXApr 16, 2018, 11:31 AM UTC
BusinessAmarantus Re-acquires Rights to Alzheimer's Blood Diagnostic LymPro TestBy Nasdaq OMXApr 6, 2018, 3:24 PM UTC